Centene Corp at Barclays Global Healthcare Conference Transcript

Mar 14, 2023 / 01:00PM GMT
Steven James Valiquette - Barclays Bank PLC, Research Division - Research Analyst

I'm Steve Valiquette, the health care services analyst here at Barclays. Welcome to our next session with Centene. With us from the company, we have Sarah London, company's CEO; and also Drew Asher, CFO, as well; and Jen Gilligan from IR in the audience here. So this will be a fireside chat. So I guess with that, we'll just kick right off here. Welcome, first of all.

Sarah M. London - Centene Corporation - CEO & Director

Thank you.

Questions and Answers:

Steven James Valiquette - Barclays Bank PLC, Research Division - Research Analyst

All right. Great. So I guess just starting around the redeterminations. Obviously, that's going to be top of mind for a lot of investors right now. And also, I think, some debate around the overall MLR impact related to redeterminations. I think on the one hand, you have some members enrolled in commercial exchange plans typically generate higher PMPMs and Medicaid members. There's also some
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot